Cytotoxic effects of 2-arylbenzofuran phytoestrogens on human cancer cells: Modulation by adrenal and gonadal steroids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 104, Issue 3-5, 2007, Pages 228-236

  Katsanou, Efrosini S ^a   Halabalaki, Maria ^b   Aligiannis, Nektarios ^b   Mitakou, Sofia ^b   Skaltsounis, Alexios Leandros ^b   Alexi, Xanthippi ^a   Pratsinis, Harris ^c   Alexis, Michael N ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Anticancer activity; Arylbenzofurans; Breast cancer; Dehydroepiandrosterone; Estradiol; Leguminosae; MCF 7 cells; Onobrychis ebenoides

Indexed keywords

BENZOFURAN DERIVATIVE; CORTICOSTEROID; EBENFURAN I; EBENFURAN II; EBENFURAN III; ESTRADIOL; ESTROGEN RECEPTOR; PHYTOALEXIN; PHYTOESTROGEN; PRASTERONE; PROTEIN BAX; PROTEIN BCL 2; SEX HORMONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; LEGUME; ONOBRYCHIS EBENOIDES;

ADRENAL GLANDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOFURANS; BREAST NEOPLASMS; CATECHOLS; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXINS; DRUG INTERACTIONS; FURANS; GONADAL STEROID HORMONES; HELA CELLS; HT29 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; PHYTOESTROGENS; STEROIDS; TERPENES; TUMOR CELLS, CULTURED;

FABACEAE; ONOBRYCHIS EBENOIDES;

EID: 34250196461     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.03.028     Document Type: Article

References (35)

1. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 3 (2000) 427-433
2. Luo S., Sourla A., Labrie C., Belanger A., and Labrie F. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Endocrinology 138 10 (1997) 4435-4444
3. Vihko P., Herrala A., Harkonen P., Isomaa V., Kaija H., Kurkela R., and Pulkka A. Control of cell proliferation by steroids: the role of 17HSDs. Mol. Cell. Endocrinol. 248 1-2 (2006) 141-148
4. van Landeghem A.A., Poortman J., Nabuurs M., and Thijssen J.H. Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue. Cancer Res. 45 6 (1985) 2907-2912
5. van Landeghem A.A., Poortman J., Nabuurs M., and Thijssen J.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 45 6 (1985) 2900-2906
6. Jensen J., Kitlen J.W., Briand P., Labrie F., and Lykkesfeldt A.E. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium. J. Steroid Biochem. Mol. Biol. 84 4 (2003) 469-478
7. Lazennec G., Alcorn J.L., and Katzenellenbogen B.S. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Mol. Endocrinol. 13 6 (1999) 969-980
8. Shafie S.M., and Grantham F.H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. Natl. Cancer Inst. 67 1 (1981) 51-56
9. Perillo B., Sasso A., Abbondanza C., and Palumbo G. 17beta-estradiol inhibits apoptosis in MCF-7 cells, by inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 20 8 (2000) 2890-2901
10. Kyprianou N., English H.F., Davidson N.E., and Isaacs J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51 1 (1991) 162-166
11. Kinghorn A.D., Su B.N., Jang D.S., Chang L.C., Lee D., Gu J.Q., Carcache-Blanco E.J., Pawlus A.D., Lee S.K., Park E.J., Cuendet M., Gills J.J., Bhat K., Park H.S., Mata Greenwood E., Song L.L., Jang M., and Pezzuto J.M. Natural inhibitors of carcinogenesis. Planta Med. 70 8 (2004) 691-705
12. Han S.J., Ryu S.N., and Kang S.S. A new 2-arylbenzofuran with antioxidant activity from the black colored rice (Oryza sativa L.) bran. Chem. Pharm. Bull. 52 11 (2004) 1365-1366
13. Russell B.G., Shaw G.J., Christmas E.P., Yates B.M., and Sutherland R.W.O. Two 2-arylbenzofurans as insect feeding deterrents from sainfoin (Onobrychis viciifolia). Phytochemistry 23 (1984) 1417-1420
14. Halabalaki M., Aligiannis N., Papoutsi Z., Mitaku S., Moutsatsou P., Sekeris C., and Skaltsounis A.L. Three new arylbenzofurans from Onobrychis ebenoides and evaluation of their binding affinity for the estrogen receptor. J. Nat. Prod. 63 12 (2000) 1672-1674
15. Papoutsi Z., Kassi E., Papaevangeliou D., Pratsinis H., Zoumpourlis V., Halabalaki M., Mitakou S., Kalofoutis A., and Moutsatsou P. Plant 2-arylobenzofurans demonstrate a selective estrogen receptor modulator profile. Steroids 69 11-12 (2004) 727-734
16. Fokialakis N., Lambrinidis G., Mitsiou D.J., Aligiannis N., Mitakou S., Skaltsounis A.L., Pratsinis H., Mikros E., and Alexis M.N. A new class of phytoestrogens: evaluation of the estrogenic activity of deoxybenzoins. Chem. Biol. 11 3 (2004) 397-406
17. Paine T.M., Soule H.D., Pauley R.J., and Dawson P.J. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int. J. Cancer 50 3 (1992) 463-473
18. Beck W.T., Mueller T.J., and Tanzer L.R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res. 39 6 Pt. 1 (1979) 2070-2076
19. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 6652 (1997) 753-758
20. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., and Greene G.L. The structural basis of estrogen receptor coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 7 (1998) 927-937
21. Pike A.C.W., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., and Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18 17 (1999) 4608-4618
22. Shiau A.K., Barstad D., Radek J.T., Meyers M.J., Nettles K.W., Katzenellenbogen B.S., Katzenellenbogen J.A., Agard D.A., and Greene G.L. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat. Struct. Biol. 9 5 (2002) 359-364
23. Halabalaki M., Alexi X., Aligiannis N., Lambrinidis G., Pratsinis H., Florentin I., Mitakou S., Mikros E., Skaltsounis A.L., and Alexis M.N. Estrogenic activity of isoflavonoids from Onobrychis ebenoides. Planta Med. 72 6 (2006) 488-493
24. Chun T.Y., Gregg D., Sarkar D.K., and Gorski J. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth. Proc. Natl. Acad. Sci. U.S.A. 95 5 (1998) 2325-2330
25. Katsanou E.S., and Alexis M.N. Hormonal effects of dehydroepiandrosterone on breast cancer cells. Proceedings of the 55th meeting of the Hellenic Society of Biochemistry and Molecular Biology, vol. 50 (2003), HSBMB Newsletter 300-304
26. Schulze A., Lehmann K., Jefferies H.B., McMahon M., and Downward J. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15 8 (2001) 981-994
27. Carlson B.A., Dubay M.M., Sausville E.A., Brizuela L., and Worland P.J. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res. 56 13 (1996) 2973-2978
28. Hong C., Kim H.A., Firestone G.L., and Bjeldanes L.F. 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23 8 (2002) 1297-1305
29. Kirkin V., Joos S., and Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta 1644 2-3 (2004) 229-249
30. Rytomaa M., Lehmann K., and Downward J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19 39 (2000) 4461-4468
31. Shao Z.M., Wu J., Shen Z.Z., and Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58 21 (1998) 4851-4857
32. Po L.S., Wang T.T., Chen Z.Y., and Leung L.K. Genistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects. Br. J. Nutr. 88 5 (2002) 463-469
33. Jiang M., and Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev. 17 7 (2003) 832-837
34. Shi Y.Q., Fukai T., Sakagami H., Chang W.J., Yang P.Q., Wang F.P., and Nomura T. Cytotoxic flavonoids with isoprenoid groups from Morus mongolica. J. Nat. Prod. 64 2 (2001) 181-188
35. Chang J.Y., Chang C.Y., Kuo C.C., Chen L.T., Wein Y.S., and Kuo Y.H. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Mol. Pharmacol. 65 1 (2004) 77-84